NCT01632839

Brief Summary

The primary objective of this study is the psychometric validation of two questionnaires (PISQ-R and a new questionnaire on sexuality) as compared to a non specific questionnaire on female sexual function (FSFI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
298

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 3, 2012

Completed
7 months until next milestone

Study Start

First participant enrolled

January 18, 2013

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2017

Completed
Last Updated

November 19, 2025

Status Verified

July 1, 2017

Enrollment Period

4.3 years

First QC Date

June 29, 2012

Last Update Submit

November 17, 2025

Conditions

Keywords

PISQ-Rnew sexuality questionnaire

Outcome Measures

Primary Outcomes (1)

  • PISQ-R questionnaire

    12 months + 1 week

Secondary Outcomes (19)

  • PISQ-R questionnaire

    baseline; day 0

  • PISQ-R questionnaire

    6 months

  • PISQ-R questionnaire

    12 months

  • New sexuality questionnaire

    baseline; day 0

  • New sexuality questionnaire

    6 months

  • +14 more secondary outcomes

Study Arms (8)

Vaginal surgery +prothesis +sexuality

The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are sexually active.

Vaginal surgery +prothesis -sexuality

The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are NOT sexually active.

Vaginal surgery -prothesis + sexuality

The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are sexually active.

Vaginal surgery -prothesis -sexuality

The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are NOT sexually active.

Abdominal surgery +sexuality

The 50 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are sexually active.

Abdominal surgery -sexuality

The 25 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are NOT sexually active.

Urinary incontinence surgery + sexuality

The 50 patients included in this group will have surgery for urinary incontinence; these patients are sexually active.

Urinary incontinence surgery - sexuality

The 25 patients included in this group will have surgery for urinary incontinence; these patients are NOT sexually active.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing vaginal, abdominal or urinary incontinence surgery.

You may qualify if:

  • Patient is not pregnant
  • Patient can read and understand French
  • The patient must have given her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient has genital prolapse and/or urinary incontinence and/or anal incontinence, and have undergone surgery

You may not qualify if:

  • The patient is under judicial protection
  • The patient does not understand french
  • Patient has vulvodynia
  • Patient has painful bladder syndrome
  • The patient has had chronic pelvic pain for longer than 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

APHP - Hôpital Antoine Beclere

Clamart, 92141, France

Location

CHU de Clermont Ferrand - Hôpital Estaing

Clermont-Ferrand, 63003, France

Location

G.C.S. Flandre Maritime - site Polyclinique de Grande-Synthe

Grande-Synthe, 59760, France

Location

CH de la Rochelle

La Rochelle, 17019, France

Location

APHP - Centre Hospitalier Universitaire de Bicêtre

Le Kremlin-Bicêtre, 94275, France

Location

CHRU de Lille - Hôpital Jeanne de Flandre

Lille, 59037, France

Location

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

Groupe Hospitalier Dioconesses - Site Reuilly

Paris, 75012, France

Location

APHP - Hôpital Bichat - Claude Bernard

Paris, 75877, France

Location

CHU de Poitiers

Poitiers, 86021, France

Location

CH de la Région d'Annecy

Pringy, 74374, France

Location

CH de Poissy - Saint-Germain-en-Laye

Saint-Germain-en-Laye, 78100, France

Location

CHRU de Strasbourg - Hôpital de Hautepierre

Strasbourg, 67098, France

Location

Hôpital Foch

Suresnes, 92151, France

Location

Related Publications (1)

  • Fatton B, Hermieu JF, Lucot JP, Debodinance P, Cour F, Alonso S, de Tayrac R. French validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2021 Dec;32(12):3183-3198. doi: 10.1007/s00192-020-04625-6. Epub 2021 Jan 5.

MeSH Terms

Conditions

SexualityPelvic Organ ProlapseUrinary IncontinenceFecal Incontinence

Condition Hierarchy (Ancestors)

Sexual BehaviorBehaviorProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsRectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Renaud de Tayrac, MD PhD

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR
  • Brigitte Fatton, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2012

First Posted

July 3, 2012

Study Start

January 18, 2013

Primary Completion

April 20, 2017

Study Completion

April 20, 2017

Last Updated

November 19, 2025

Record last verified: 2017-07

Locations